NASDAQ:CVLB Conversion Labs - CVLB Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Conversion Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Add Compare Share Share Today's Range$1.15▼$1.2550-Day Range$14.48▼$30.5552-Week Range$0.50▼$33.02Volume96,702 shsAverage Volume1.05 million shsMarket Capitalization$27.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileInsider TradesInstitutional OwnershipHeadlinesShort InterestSocial Media About Conversion Labs (NASDAQ:CVLB) StockConversion Labs, Inc. operates as a direct response healthcare company that provides over the counter products and prescription medications to consumers worldwide. The company's products include Shapiro MD, a shampoo, conditioner, and leave-in-foamer for treating hair loss; iNR Wellness MD, a nutritional supplement for immune and gut support; RexMD for the treatment of cold sores, mental health, and various other medical conditions faced by men; SOSRx, a telemedicine brand that offers prescription medications and over-the-counter emergency preparation supplies for disaster situations, such as flu epidemics, bacterial outbreaks, bioterrorism and water supply failures, and others; and PDFSimpli, a PDF conversion software enables users to convert, edit, and sign PDF documents. It markets and sells its products through advertisements on Facebook, Google, Amazon, and other social media and e-commerce platforms. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was founded in 1994 and is based in New York, New York.Read More Receive CVLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Conversion Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address CVLB Stock News HeadlinesMarch 3, 2023 | msn.comLabs at the mall? Why not. Top floor of CambridgeSide set to become lab spaceFebruary 10, 2023 | msn.comMore labs aim for hot corner of the South EndMarch 23, 2023 | Health Sector Insight (Ad)Penny Stock Shows Big PotentialThe $4.37 trillion wellness market and the little-known penny stock to get on radar now. November 20, 2022 | finance.yahoo.comGrafana Labs Partners with Isovalent to Bring Best-in-Class Grafana Observability to Cilium's Service Connectivity on KubernetesSeptember 21, 2022 | investing.comCVLB_old Historical DataMay 19, 2022 | msn.comThe Shortage of Lab Space in the United States Is Stifling InnovationOctober 22, 2021 | seekingalpha.comLFMDMay 6, 2021 | benzinga.comSHAREHOLDER ALERT: Robbins LLP Reminds Investors...March 23, 2023 | Health Sector Insight (Ad)Penny Stock Shows Big PotentialThe $4.37 trillion wellness market and the little-known penny stock to get on radar now. February 26, 2021 | reuters.comLifeMD IncFebruary 22, 2021 | finance.yahoo.comConversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMDFebruary 17, 2021 | finance.yahoo.comConversion Labs to Present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2021February 5, 2021 | finance.yahoo.comConversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial OfficerFebruary 1, 2021 | markets.businessinsider.comWhy Conversion Labs Stock Is Trading Higher TodayJanuary 19, 2021 | finance.yahoo.comConversion Labs Expects 2020 Revenue up 205% to Record $38.0 Million, Subscription ARR up 525% to $26.0 MillionJanuary 11, 2021 | finance.yahoo.comConversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical OfficerDecember 10, 2020 | marketwatch.comConversion Labs Inc. (CVLB) Featured in Virtual Coverage of Benzinga's Global Small Cap ConferenceNovember 18, 2020 | seekingalpha.comConversion Labs' (CVLB) CEO Justin Schreiber on Q3 2020 Results - Earnings Call TranscriptNovember 16, 2020 | finance.yahoo.comConversion Labs Q3 2020 Revenue up 252% to Record $11.0 MillionNovember 9, 2020 | benzinga.comConversion Labs to Host Third Quarter Conference Call on Monday, November 16, 2020 at 4:30 p.m. ETNovember 4, 2020 | finance.yahoo.comConversion Labs Closes Initial Round of $15 Million Private Placement with Institutional Investors, Advances Toward Nasdaq UplistingOctober 21, 2020 | seekingalpha.comConversion Labs appoints former White House physician to boardOctober 21, 2020 | finance.yahoo.comConversion Labs Appoints Former White House Physician and U.S. Navy Rear Admiral, Dr. Connie Mariano, to Board of DirectorsOctober 14, 2020 | seekingalpha.comConversion Labs announces reverse split, 1-for-5 common sharesOctober 12, 2020 | seekingalpha.comConversion Labs reports Q3 prelimOctober 12, 2020 | markets.businessinsider.comConversion Labs Expects Q3 2020 Record Revenue of $11.2 Million, up 254%; Subscription ARR Hits $19.3 million, up 458%September 16, 2020 | seekingalpha.comConversion Labs closes $3.5M equity investment, submits application for Nasdaq listingSee More Headlines Receive CVLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Conversion Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Miscellaneous Manufacturing Industries Sub-IndustryN/A SectorRetail/Wholesale Current SymbolNASDAQ:CVLB CUSIPN/A CIKN/A Webwww.conversionlabs.com Phone(866) 351-5907FaxN/AEmployees26Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,140,000.00 Net Margins-95.36% Pretax MarginN/A Return on EquityN/A Return on Assets-761.95% Debt Debt-to-Equity RatioN/A Current Ratio0.49 Quick Ratio0.30 Sales & Book Value Annual Sales$12.47 million Price / Sales2.17 Cash FlowN/A Price / Cash FlowN/A Book Value($0.11) per share Price / Book-10.64Miscellaneous Outstanding Shares23,181,000Free FloatN/AMarket Cap$27.12 million OptionableNot Optionable Beta1.37 Key ExecutivesMr. Justin Schreiber (Age 38)Pres, CEO & Chairman Comp: $52kMr. Juan Manuel Piñeiro Dagnery (Age 34)Chief Financial Officer Comp: $111.97kMr. Stefan Galluppi (Age 34)CTO & Director Comp: $111kMr. Sean Fitzpatrick (Age 38)Pres of LegalSimpli Software LLC Comp: $119.27kMr. Brad Roberts (Age 41)Chief Operating Officer Mr. Eric H. Yecies (Age 43)Chief Compliance Officer & Gen. Counsel Dr. Joseph V. DiTrolio (Age 70)Chief Medical Officer of US & Independent Director Mr. Bryant Patrick HusseyChief Digital OfficerDr. Anthony David Puopolo IIChief Medical OfficerMore ExecutivesKey CompetitorsBurgerFi InternationalNASDAQ:BFITreasure GlobalNASDAQ:TGLMuscle MakerNASDAQ:GRILGood Times RestaurantsNASDAQ:GTIMRocky Mountain Chocolate FactoryNASDAQ:RMCFView All Competitors CVLB Stock - Frequently Asked Questions What is Conversion Labs' stock symbol? Conversion Labs trades on the NASDAQ under the ticker symbol "CVLB." What is Conversion Labs' stock price today? One share of CVLB stock can currently be purchased for approximately $1.17. How much money does Conversion Labs make? Conversion Labs (NASDAQ:CVLB) has a market capitalization of $27.12 million and generates $12.47 million in revenue each year. How can I contact Conversion Labs? Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The official website for the company is www.conversionlabs.com. The company can be reached via phone at (866) 351-5907 or via email at info@conversionlabs.com. This page (NASDAQ:CVLB) was last updated on 3/23/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.